Abstract
Liver transplantation represents a potentially curative intervention for patients with hepatocellular carcinoma and in fact is an important indication for transplant evaluation. However, early experiences with liver transplantation for this indication were characterized by dismal outcomes, mediated by high rates of posttransplant cancer recurrence. Based on these early experiences, the role of liver transplant for HCC patients was in serious doubt. This chapter reviews the importance of, and the substantial challenges confronting, the Milan Criteria. These criteria are currently used by the global transplant community to determine transplant candidacy of HCC patients. It was the development of these criteria which allowed identification of a subset of HCC patients who are predicted to have good outcomes after liver transplantation. This in turn ensured the continued role of liver transplantation as a lifesaving therapeutic intervention for this group of patients. This chapter reviews the data leading to the development of the Milan Criteria and their validation and discusses some current challenges to the application of these criteria to patients under consideration for liver transplant today.
Abbreviations
- AASLD:
-
American Association for the Study of Liver Disease
- APASL:
-
Asian Pacific Association for the Study of the Liver
- BCLC:
-
Barcelona Clinic Liver Cancer
- EASL:
-
European Association for the Study of the Liver
- HBV:
-
Hepatitis B virus
- HCC:
-
Hepatocellular carcinoma
- HCV:
-
Hepatitis C virus
- LI-RADS:
-
Liver Imaging Reporting and Data System
- NIH:
-
National Institutes of Health
- OPTN:
-
Organ Procurement and Transplantation Network
- UNOS:
-
United Network for Organ Sharing
References
Adler M, De Pauw F, Vereerstraeten P et al (2008) Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the Eurotransplant allocation system. Liver Transpl 14(4):526–533. doi: 10.1002/lt.21399
Anonymous (1984) National Institutes of health consensus development conference statement: liver2 transplantation-June 20–23, 1983. Hepatology 4(S1):107S–110S. doi:10.1002/hep.1840040725
Anonymous (2015) Transplant surgery plenary II. Hepatology 62:211A–213A. doi:10.1002/hep.28167
Befeler AS, Hayashi PH, Di Bisceglie AM (2005) Liver transplantation for hepatocellular carcinoma. Gastroenterology 128(6):1752–1764. doi:10.1053/j.gastro.2005.03.033
Bismuth H (1987) Liver transplantation: a subtle revolution. Br J Surg 74(5):339–340. doi:10.1002/bjs.1800740502
Bismuth H, Chiche L, Adam R et al (1993) Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 218(2):145–151
Bruix J, Sherman M, American Association for the Study of Liver Diseases (2011) Management of hepatocellular carcinoma: an update. Hepatology 53(3):1020–1022. doi:10.1002/hep.24199;10.1002/hep.24199
Chen L, Zhang L, Liang M et al (2014) Magnetic resonance imaging with gadoxetic acid disodium for the detection of hepatocellular carcinoma: a meta-analysis of 18 studies. Acad Radiol 21(12):1603–1613. doi:10.1016/j.acra.2014.08.003
Chou R, Cuevas C, Fu R et al (2015) Imaging techniques for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. Ann Intern Med 162(10):697–711. doi:10.7326/M14-2509
Decaens T, Roudot-Thoraval F, Hadni-Bresson S et al (2006) Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time. Liver Transpl 12(12):1761–1769. doi:10.1002/lt.20884
El-Serag HB (2004) Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 127(5 Suppl 1):S27–S34. doi:10.1053/j.gastro.2004.09.013
El-Serag HB (2011) Hepatocellular carcinoma. N Engl J Med 365(12):1118–1127. doi:10.1056/NEJMra1001683,10.1056/NEJMra1001683
European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56(4):908–943
Figueras J, Jaurrieta E, Valls C et al (1997) Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology 25(6):1485–1489. S0270913997002814 [pii]
Fowler KJ, Karimova EJ, Arauz AR et al (2013) Validation of organ procurement and transplant network (OPTN)/united network for organ sharing (UNOS) criteria for imaging diagnosis of hepatocellular carcinoma. Transplantation 95(12):1506–1511. doi:10.1097/TP.0b013e31828eeab2
Freeman RB, Mithoefer A, Ruthazer R et al (2006) Optimizing staging for hepatocellular carcinoma before liver transplantation: a retrospective analysis of the UNOS/OPTN database. Liver Transpl 12(10):1504–1511. doi:10.1002/lt.20847
Haug CE, Jenkins RL, Rohrer RJ et al (1992) Liver transplantation for primary hepatic cancer. Transplantation 53(2):376–382
Herrero JI, Sangro B, Pardo F et al (2008) Liver transplantation in patients with hepatocellular carcinoma across Milan criteria. Liver Transpl 14(3):272–278. doi:10.1002/lt.21368
HRSA/OPTN (2015a) Policy 9: allocation of livers and liver-intestines. http://optn.transplant.hrsa.gov/ContentDocuments/OPTN_Policies.pdf. Published 2015. Accessed 31 Aug 2015
HRSA/OPTN (2015b) UNOS policy notice: changes to OPTN bylaws and policies. http://optn.transplant.rsa.gov/governance/policy-notices/. Published 12 Dec 2014. Accessed 24 Nov 2015
Ismail T, Angrisani L, Gunson BK et al (1990) Primary hepatic malignancy: the role of liver transplantation. Br J Surg 77(9):983–987
Iwatsuki S, Gordon RD, Shaw BW Jr et al (1985) Role of liver transplantation in cancer therapy. Ann Surg 202(4):401–407
Iwatsuki S, Starzl TE, Sheahan DG et al (1991) Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 214(3):221–228 (discussion 228–229)
Jenkins RL, Pinson CW, Stone MD (1989) Experience with transplantation in the treatment of liver cancer. Cancer Chemother Pharmacol 23(Suppl):S104–S109
Junqiang L, Yinzhong W, Li Z et al (2014) Gadoxetic acid disodium (Gd-EOBDTPA)-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: a meta-analysis. J Magn Reson Imaging 39(5):1079–1087
Kierans AS, Kang SK, Rosenkrantz AB (2015) The diagnostic performance of dynamic contrast-enhanced MR Imaging for detection of small hepatocellular carcinoma measuring up to 2 cm: a meta-analysis. Radiology 278(1):82–94. doi:10.1148/radiol.2015150177
Kim WR, Lake JR, Smith JM et al (2015) OPTN/SRTR 2013 annual data report: liver. Am J Transplant 15(Suppl 2):1–28. doi:10.1111/ajt.13197
Kneteman NM, Oberholzer J, Al Saghier M et al (2004) Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma. Liver Transpl 10(10):1301–1311. doi:10.1002/lt.20237
Koneru B, Cassavilla A, Bowman J et al (1988) Liver transplantation for malignant tumors. Gastroenterol Clin North Am 17(1):177–193
Leung JY, Zhu AX, Gordon FD et al (2004) Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study. Liver Transpl 10(11):1343–1354. doi:10.1002/lt.20311
Llovet JM, Bruix J, Fuster J et al (1998) Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology 27(6):1572–1577. S0270913998002353 [pii]
Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334(11):693–699. doi:10.1056/NEJM199603143341104
Mazzaferro V, Llovet JM, Miceli R et al (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10(1):35–43. doi:10.1016/S1470-2045(08)70284-5;10.1016/S1470-2045(08)70284-5
Mazzaferro V, Bhoori S, Sposito C et al (2011) Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience. Liver Transpl 17(Suppl 2):S44–S57. doi:10.1002/lt.22365,10.1002/lt.22365
McPeake JR, O'Grady JG, Zaman S et al (1993) Liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome. J Hepatol 18(2):226–234
Merli M, Nicolini G, Gentili F et al (2005) Predictive factors of outcome after liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Transplant Proc 37(6):2535–2540. S0041-1345(05)00670-6 [pii]
Mitchell DG, Bruix J, Sherman M et al (2015) LI-RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI-RADS Management Working Group and future directions. Hepatology 61(3):1056–1065
Moreno Gonzalez E, Gomez R, Garcia I et al (1992) Liver transplantation in malignant primary hepatic neoplasms. Am J Surg 163(4):395–400
O'Grady JG, Polson RJ, Rolles K et al (1988) Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg 207(4):373–379
Olthoff KM, Millis JM, Rosove MH et al (1990) Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg 125(10):1261–1266 (discussion 1266–1268)
Omata M, Lesmana LA, Tateishi R et al (2010) Asian Pacific Association for the study of the liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 4(2):439–474. doi:10.1007/s12072-010-9165-7
Onaca N, Davis GL, Jennings LW et al (2009) Improved results of transplantation for hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl 15(6):574–580. doi:10.1002/lt.21738
Pelletier SJ, Fu S, Thyagarajan V et al (2009) An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data. Liver Transpl 15(8):859–868. doi:10.1002/lt.21778
Pichlmayr R (1988) Is there a place for liver grafting for malignancy? Transplant Proc 20(1 Suppl 1):478–482
Pichlmayr R, Weimann A, Oldhafer KJ et al (1995) Role of liver transplantation in the treatment of unresectable liver cancer. World J Surg 19(6):807–813
Pomfret EA, Washburn K, Wald C et al (2010) Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl 16(3):262–278
Raj A, McCall J, Gane E (2011) Validation of the "Metroticket" predictor in a cohort of patients transplanted for predominantly HBV-related hepatocellular carcinoma. J Hepatol 55(5):1063–1068
Ravaioli M, Ercolani G, Cescon M et al (2004) Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. Liver Transpl 10(9):1195–1202. doi:10.1002/lt.20239
Ringe B, Wittekind C, Bechstein WO et al (1989) The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg 209(1):88–98
Ringe B, Pichlmayr R, Wittekind C et al (1991) Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 15(2):270–285
Sanyal AJ, Yoon SK, Lencioni R (2010) The etiology of hepatocellular carcinoma and consequences for treatment. Oncologist 15(Suppl 4):14–22
Scharschmidt BF (1984) Human liver transplantation: analysis of data on 540 patients from four centers. Hepatology 4(S1):95S–101S. doi:10.1002/hep.1840040723
Schlansky B, Naugler WE, Civan JM (2015) Organ procurement and transplantation network policies – Policy 9: Allocation of livers and liver-intestines
Selby R, Kadry Z, Carr B et al (1995) Liver transplantation for hepatocellular carcinoma. World J Surg 19(1):53–58
Shah SA, Tan JC, McGilvray ID et al (2006) Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma. Transplantation 81(12):1633–1639. doi:10.1097/01.tp.0000226069.66819.7e
Shetty K, Timmins K, Brensinger C et al (2004) Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl 10(7):911–918. doi:10.1002/lt.20140
Sotiropoulos GC, Lang H, Nadalin S et al (2007) Liver transplantation for hepatocellular carcinoma: University Hospital Essen experience and metaanalysis of prognostic factors. J Am Coll Surg 205(5):661–675. S1072-7515(07)00690-4 [pii]
Starzl TE, Klintmalm GB, Porter KA et al (1981) Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med 305(5):266–269. doi:10.1056/NEJM198107303050507
Tan KC, Rela M, Ryder SD et al (1995) Experience of orthotopic liver transplantation and hepatic resection for hepatocellular carcinoma of less than 8 cm in patients with cirrhosis. Br J Surg 82(2):253–256
Todo S, Furukawa H, Japanese Study Group on Organ Transplantation (2004) Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg 240(3):451–459; discussion 459–461, 00000658-200409000-00006 [pii]
Vakili K, Pomposelli JJ, Cheah YL et al (2009) Living donor liver transplantation for hepatocellular carcinoma: increased recurrence but improved survival. Liver Transpl 15(12):1861–1866. doi:10.1002/lt.21940
Wald C, Russo MW, Heimbach JK et al (2013) New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology 266(2):376–382
Wiesner RH, Freeman RB, Mulligan DC (2004) Liver transplantation for hepatocellular cancer: The impact of the MELD allocation policy. Gastroenterology 127(5 Supplement 1):S261–S267. doi:10.1053/j.gastro.2004.09.040
Xiao L, Fu ZR, Ding GS et al (2009) Liver transplantation for hepatitis B virus-related hepatocellular carcinoma: one center's experience in China. Transplant Proc 41(5):1717–1721. doi:10.1016/j.transproceed.2009.03.058
Yao FY, Ferrell L, Bass NM et al (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33(6):1394–1403. S0270913901475495 [pii]
Yao FY, Ferrell L, Bass NM et al (2002) Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 8(9):765–774. S1527646502000333 [pii]
Yokoyama I, Todo S, Iwatsuki S et al (1990) Liver transplantation in the treatment of primary liver cancer. Hepatogastroenterology 37(2):188–193
Zavaglia C, De Carlis L, Alberti AB et al (2005) Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol 100(12):2708–2716. AJG289 [pii]
Zheng SS, Xu X, Wu J et al (2008) Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation 85(12):1726–1732. doi:10.1097/TP.0b013e31816b67e4
Zimmerman MA, Trotter JF, Wachs M et al (2007) Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience. Transpl Int 20(9):747–753. TRI505 [pii]
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing AG
About this entry
Cite this entry
Civan, J.M. (2016). Liver Transplantation for HCC: The Milan Criteria. In: Doria, C. (eds) Contemporary Liver Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-05543-5_11-2
Download citation
DOI: https://doi.org/10.1007/978-3-319-05543-5_11-2
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Online ISBN: 978-3-319-05543-5
eBook Packages: Springer Reference MedicineReference Module Medicine
Publish with us
Chapter history
-
Latest
Liver Transplantation for HCC: The Milan Criteria- Published:
- 11 October 2016
DOI: https://doi.org/10.1007/978-3-319-05543-5_11-2
-
Original
Liver Transplantation for HCC: The Milan Criteria- Published:
- 11 June 2016
DOI: https://doi.org/10.1007/978-3-319-05543-5_11-1